Dilsher S. Dhoot, MD discusses a recent case-based roundtable meeting on anti-VEGF biosimilars, highlighting the first of two case discussions.
Examining Anti-VEGF Biosimilars in the Management of Retinal Diseases
Dilsher S. Dhoot, MD discusses a recent case-based roundtable meeting on anti-VEGF biosimilars, highlighting the first of two case discussions.
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
What if? Ophthalmology without OCT – Part 5
2
LASIK and beyond: Navigating the changing landscape of refractive surgery
3
Q&A: James Chelnis discusses AAO 2025 presentation on aesthetic facial surgery
4
Throwback Series: A biopsy, a lesson, and the courage to speak up
5
.png "Optometry Times"){kind=logo}
